Invivyd (IVVD) Retained Earnings (2021 - 2025)
Invivyd (IVVD) reported Retained Earnings of -$954.5 million for Q4 2025, down 5.82% on a YoY basis from -$1.0 billion in Q4 2024, and down 1.17% quarter-over-quarter from -$943.4 million in Q3 2025.
Invivyd (IVVD) Retained Earnings (2021 - 2025) Analysis & Trends
Invivyd has reported Retained Earnings for 5 years, with the latest figure at -$954.5 million in Q4 2025.
- For the quarter ending Q4 2025, Retained Earnings fell 5.82% year-over-year to -$954.5 million; the trailing twelve-month figure through Dec 2025 stood at -$954.5 million (down 5.82% YoY), and the FY2025 full-year result was -$954.5 million, down 5.82% from the prior year.
- Retained Earnings for Q4 2025 stood at -$954.5 million, down from -$943.4 million in the prior quarter.
- The five-year high for Retained Earnings was $3000.0 in Q3 2021, with the low at -$954.5 million in Q4 2025.
- Historically, Retained Earnings has averaged -$371.8 million across 5 years, with a median of -$296.2 million in 2021.
- Annual changes were most pronounced in 2023 — Retained Earnings jumped 100.0% — and 2024, when it tumbled 44179900.0%.
- Invivyd's Retained Earnings stood at -$8000.0 in 2021, then sank by 6667725.0% to -$533.4 million in 2022, then soared by 100.0% to -$13000.0 in 2023, then tumbled by 6938315.38% to -$902.0 million in 2024, then fell by 5.82% to -$954.5 million in 2025.
- The last three Retained Earnings figures came in at -$954.5 million (Q4 2025), -$943.4 million (Q3 2025), and -$39000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Invivyd | 168.41 Mn | -58.28 Mn | - | -954.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -954.48 Mn |
| Sep 30, 2025 | -943.41 Mn |
| Jun 30, 2025 | -39,000.00 |
| Mar 31, 2025 | -13,000.00 |
| Dec 31, 2024 | -901.99 Mn |
| Sep 30, 2024 | -883.60 Mn |
| Jun 30, 2024 | -12,000.00 |
| Mar 31, 2024 | -775.57 Mn |
| Dec 31, 2023 | -13,000.00 |
| Sep 30, 2023 | -2,000.00 |
| Jun 30, 2023 | -618.98 Mn |
| Mar 31, 2023 | -115,000.00 |
| Dec 31, 2022 | -533.43 Mn |
| Sep 30, 2022 | -488.85 Mn |
| Jun 30, 2022 | -443.77 Mn |
| Dec 31, 2021 | -8,000.00 |
| Sep 30, 2021 | 3,000.00 |
| Jun 30, 2021 | -148.70 Mn |